Fate Therapeutics Inc (FATE)

Fate Therapeutics Inc Stock (FATE) Forecast

The Fate Therapeutics Inc (FATE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.52, representing a +181.64% increase from the current price of $1.61. The highest analyst price target is $6.67, and the lowest is $2.37.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month FATE Price Target

Average 13.99 (+771.35% Upside)

Is Fate Therapeutics Inc (FATE) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	30.61	Neutral
STOCH(9,6)	17.05	Buy
STOCHRSI(14)	1.78	Buy
MACD(12,26)	-0.11	Sell
ADX(14)	13.91	Neutral
William %R	-99.21	Buy
CCI(14)	-212.50	Sell

Buy: 3 · Sell: 2 · Neutral: 2Summary: Buy

Moving Averages

Period	Simple	Exponential
MA10	1.94 Sell	1.89 Sell
MA20	1.98 Sell	1.98 Sell
MA50	2.20 Sell	2.14 Sell
MA100	2.40 Sell	2.18 Sell
MA200	1.99 Sell	2.01 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, FATE could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on FATE, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 30.61 indicates that FATE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 17.05 indicates that FATE is oversold. This indicates that FATE price is at or near the lowest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.78 indicates that FATE is oversold. This suggests that FATE price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 13.91 suggests that there may be some movement in price, but it lacks strength or conviction.
CCI (Commodity Channel Index): A CCI(14) value of -212.50 indicates that FATE is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term FATE price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Fate Therapeutics Inc financial reports and earnings history, Fate Therapeutics Inc (FATE) stock could reach $21.53 by 2030, $107.60 by 2040 and $218.94 by 2050. See the projected annual prices until 2050 of the Fate Therapeutics Inc stock below:

Fate Therapeutics Inc (FATE) is expected to reach an average price of $42.18 in 2035, with a high prediction of $58.77 and a low estimate of $42.46. This indicates an +2,528% change from the last recorded price of $1.61.
Fate Therapeutics Inc (FATE) stock is projected to chart a bullish course in 2040, with an average price target of $80.49, representing an +4,915% change from its current level. The forecast ranges from a conservative $79.69 to a sky-high $107.60.
Our analysts predict Fate Therapeutics Inc (FATE) to change +8,418% by 2045, soaring from $136.85 to an average price of $136.71, potentially reaching $160.89. While $136.85 is the low estimate, the potential upside is significant.
Fate Therapeutics Inc (FATE) stock is expected to climb by 2050, reaching an average of $198.07, a +12,241% change from its current level. However, a wide range of estimates exists, with high and low targets of $218.94 and $194.31, respectively, highlighting the market's uncertainty.

Fate Therapeutics Inc Stock (FATE) Year by Year Forecast

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2026

The predicted value for Fate Therapeutics Inc (FATE) in 2026 is set at an average of $2.24. Estimates vary from a peak of $6.67 to a trough of $0.42, indicating an +39.63% surge from the present price of $1.61.

Month	Average	Low	High	Change from today's price
December, 2026	$5.74	$2.37	$6.67	+257.72%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Fate Therapeutics Inc (FATE) is $17.95, with a high forecast of $25.60 and a low forecast of $2.53. This indicates an +1,018% increase from the last price of $1.61.

Month	Average	Low	High	Change from today's price
January, 2027	$9.03	$2.53	$13.72	+462.67%
February, 2027	$12.69	$14.60	$10.23	+690.86%
March, 2027	$18.25	$13.94	$15.60	+1,037%
April, 2027	$11.24	$13.43	$13.85	+600.37%
May, 2027	$20.57	$10.98	$12.95	+1,181%
June, 2027	$24.84	$25.06	$24.57	+1,448%
July, 2027	$26.67	$25.82	$25.60	+1,562%
August, 2027	$15.13	$19.84	$21.73	+842.47%
September, 2027	$12.30	$14.75	$12.46	+666.29%
October, 2027	$18.69	$17.15	$17.62	+1,065%
November, 2027	$23.06	$20.01	$20.88	+1,337%
December, 2027	$22.90	$23.01	$22.29	+1,327%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2028

In 2028, Fate Therapeutics Inc (FATE) is projected to reach an average price of $32.28, with a high projection of $35.80 and a low estimate of $23.28. This indicates an +1,911% rise from the last price of $1.61.

Month	Average	Low	High	Change from today's price
January, 2028	$22.11	$23.63	$22.37	+1,278%
February, 2028	$31.22	$23.28	$29.08	+1,845%
March, 2028	$36.05	$32.49	$35.80	+2,146%
April, 2028	$34.59	$34.78	$35.33	+2,055%
May, 2028	$35.05	$34.27	$34.07	+2,084%
June, 2028	$33.37	$33.78	$34.09	+1,979%
July, 2028	$33.36	$32.91	$32.75	+1,979%
August, 2028	$32.38	$32.83	$32.76	+1,917%
September, 2028	$32.16	$32.15	$31.85	+1,904%
October, 2028	$31.90	$31.87	$31.78	+1,888%
November, 2028	$32.70	$32.25	$32.50	+1,937%
December, 2028	$32.42	$32.45	$32.34	+1,920%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2029

The 2029 price forecast for Fate Therapeutics Inc Stock (FATE) is $25.42 on average, with a high prediction of $32.03 and a low estimate of $20.58. This represents an +1,484% increase from the previous price of $1.61.

Month	Average	Low	High	Change from today's price
January, 2029	$31.74	$32.07	$32.03	+1,877%
February, 2029	$30.97	$31.12	$31.54	+1,829%
March, 2029	$29.67	$30.02	$30.25	+1,749%
April, 2029	$27.67	$27.98	$29.43	+1,624%
May, 2029	$24.57	$26.30	$26.51	+1,431%
June, 2029	$23.06	$23.55	$23.73	+1,337%
July, 2029	$22.53	$22.40	$21.87	+1,303%
August, 2029	$23.64	$22.13	$22.47	+1,373%
September, 2029	$23.64	$24.02	$23.89	+1,373%
October, 2029	$23.23	$23.37	$23.47	+1,347%
November, 2029	$22.52	$23.10	$22.91	+1,303%
December, 2029	$21.87	$20.58	$20.95	+1,263%

Fate Therapeutics Inc Stock (FATE) Price Forecast for 2030

Fate Therapeutics Inc Stock (FATE) is expected to reach an average price of $18.51 in 2030, with a high forecast of $21.53 and a low forecast of $14.99. This signifies an +1,053% surge from the last price of $1.61.

Month	Average	Low	High	Change from today's price
January, 2030	$21.15	$21.21	$21.53	+1,217%
February, 2030	$20.33	$20.35	$20.34	+1,167%
March, 2030	$20.47	$20.35	$20.21	+1,175%
April, 2030	$19.95	$20.23	$20.29	+1,143%
May, 2030	$19.85	$19.53	$19.46	+1,137%
June, 2030	$19.36	$19.37	$19.63	+1,106%
July, 2030	$18.52	$18.77	$19.19	+1,054%
August, 2030	$18.29	$18.36	$18.28	+1,039%
September, 2030	$17.28	$17.66	$18.05	+976.86%
October, 2030	$16.33	$16.43	$16.99	+917.20%
November, 2030	$15.72	$15.74	$16.13	+879.34%
December, 2030	$14.92	$14.99	$15.07	+829.83%